Skip to main content
Home
FULL MENU Close Menu
Home
Home

Nancy A. Melville

News

`Paradigm shift’: Luspatercept for MDS

Author:
Nancy A. Melville
Publish date: May 25, 2023

In a first head-to-head comparison study, luspatercept for MDS significantly outperformed epoetin alfa in reducing transfusion dependence.

  • Read More

News

Diabetes, cholesterol meds use drops after bariatric surgery

Author:
Nancy A. Melville
Publish date: May 25, 2023

Undergoing bariatric surgery was associated with a substantial and long-lasting reduction in the use of lipid-lowering and antidiabetic...

  • Read More

News

Immunotherapy plus chemo improves quality of life in NSCLC

Author:
Nancy A. Melville
Publish date: May 17, 2023

The delays reported in time to definitive clinically meaningful deterioration “are particularly pertinent, given the anticipated continued...

  • Read More

News

Liquid biopsy assay can predict CRC recurrence early

Author:
Nancy A. Melville
Publish date: May 1, 2023

CRC has a relatively high recurrence rate even after curative-intent therapies.

  • Read More

News

Weight loss linked to early death in older but healthy adults

Author:
Nancy A. Melville
Publish date: April 17, 2023

“Clinicians should be aware that even minor weight loss of 5% or more in older adults without life-limiting illnesses can increase mortality risk...

  • Read More

News

Breast conservation safe even with multiple-site tumors

Author:
Nancy A. Melville
Publish date: March 29, 2023

“This is an important study confirming that breast conservation is feasible and safe for women with multiple ipsilateral breast cancers, with...

  • Read More

News

Strong support for CBT as first-line treatment for insomnia in seniors

Author:
Nancy A. Melville
Publish date: March 14, 2023

The American Academy of Sleep Medicine recommends CBT-I as first-line treatment for insomnia, with the key benefit being its exemplary safety...

  • Read More

News

New data on IV ketamine for resistant depression in the elderly

Author:
Nancy A. Melville
Publish date: March 14, 2023

Overall, 48% of participants achieved a response, and 24% achieved remission of depressive symptoms following the first 4 weeks of twice-weekly...

  • Read More

News

Add-on antipsychotic beats switching meds in older adults with resistant depression

Author:
Nancy A. Melville
Publish date: March 14, 2023

“These results are of great impact for clinicians managing older adults with treatment-resistant depression,” said Dr. Jennifer Gatchel.

  • Read More

News

Antipsychotic cuts Alzheimer’s-related agitation

Author:
Nancy A. Melville
Publish date: March 10, 2023

Brexpiprazole will become the first drug to be approved for agitation in AD, doctor speculates.

  • Read More

News

Long-acting ART effective without viral suppression

Author:
Nancy A. Melville
Publish date: February 24, 2023

“Instead of having the burden of taking a pill every day, patients with HIV can now have these choices of being able to forget about their...

  • Read More

News

Doxy PEP does not lower risk of STIs in cisgender women

Author:
Nancy A. Melville
Publish date: February 24, 2023

Women are known to be at higher risk of infection because the lining of the vagina is thinner than the skin of the penis, allowing for easier...

  • Read More

News

Meningococcal vaccine shows benefit in STI prevention

Author:
Nancy A. Melville
Publish date: February 22, 2023

“The duration of protective efficacy – a big thing in vaccines – is unknown. Still, this is really significant.”

  • Read More

News

Eight-week TB treatment strategy shows potential

Author:
Nancy A. Melville
Publish date: February 21, 2023

“Clinicians will not feel comfortable with the short regimens at this point, but it is remarkable that so many patients did well with shorter...

  • Read More

News

Transplant vs. chemo: Similar AML survival rates

Author:
Nancy A. Melville
Publish date: February 17, 2023

New study showed similar survival rates among AML patients treated solely with consolidation chemotherapy and those who received allogenic HCT.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close